GZ-793A, a lobelane analog, interacts with the vesicular monoamine transporter-2 to inhibit the effect of methamphetamine
about
The vesicular monoamine transporter-2: an important pharmacological target for the discovery of novel therapeutics to treat methamphetamine abuse.The vesicular monoamine transporter 2: an underexplored pharmacological target.Quinolyl analogues of norlobelane: novel potent inhibitors of [(3)H]dihydrotetrabenazine binding and [(3)H]dopamine uptake at the vesicular monoamine transporter-2.Iterative direct C(sp3)-H functionalization of amines: diastereoselective divergent syntheses of α,α'-disubstituted alicyclic amines.Varenicline and GZ-793A differentially decrease methamphetamine self-administration under a multiple schedule of reinforcement in rats.
P2860
GZ-793A, a lobelane analog, interacts with the vesicular monoamine transporter-2 to inhibit the effect of methamphetamine
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
GZ-793A, a lobelane analog, in ...... the effect of methamphetamine
@en
GZ-793A, a lobelane analog, in ...... the effect of methamphetamine.
@nl
type
label
GZ-793A, a lobelane analog, in ...... the effect of methamphetamine
@en
GZ-793A, a lobelane analog, in ...... the effect of methamphetamine.
@nl
prefLabel
GZ-793A, a lobelane analog, in ...... the effect of methamphetamine
@en
GZ-793A, a lobelane analog, in ...... the effect of methamphetamine.
@nl
P2093
P2860
P356
P1476
GZ-793A, a lobelane analog, in ...... the effect of methamphetamine
@en
P2093
David B Horton
Guangrong Zheng
Justin R Nickell
Linda P Dwoskin
Peter A Crooks
P2860
P304
P356
10.1111/JNC.12371
P407
P577
2013-08-19T00:00:00Z